Clinical Trial Update: Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating the immunoregulatory effects of immunoglobulin induction therapy in renal transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplantation

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of Giessen | Conditions: Renal Failure, Chronic, Renal Transplantation | EARLY_Phase 1 | Status: COMPLETED